术前奥昔布宁减少常见小儿泌尿外科手术后阿片类药物使用
该单机构回顾性研究纳入134例留置尿道和/或输尿管引流管的小儿泌尿外科手术患者,其中42例术前接受单次按体重计算的奥昔布宁口服,92例未接受。术前奥昔布宁组术后阿片类药物使用率为19%,未使用组为47%;多变量逻辑回归显示术前奥昔布宁与术后阿片类药物使用风险降低77%相关(比值比0.23,95%CI 0.09-0.56,P<.001)。
要点
- 术前单次奥昔布宁组术后阿片类药物使用率19%,未使用组47%。
- 多变量分析示术前奥昔布宁与术后阿片使用风险降低77%相关(OR 0.23)。
- 该干预风险较低且易于实施。
核心结论
- 对于泌尿外科术后留置尿道引流管的小儿患者,术前单次奥昔布宁剂量与术后阿片类药物使用率较低显著相关。
- 该风险相对较低的干预措施易于实施。
研究设计与样本
- 单机构回顾性研究,纳入接受泌尿 tract 手术并同时放置尿道和/或输尿管引流管的小儿患者。
- 患者在术前区域接受单次按体重计算的口服奥昔布宁剂量。
- 最终研究人群共134例,其中42例接受奥昔布宁,92例未接受。
- 主要结局为术后是否接受阿片类药物,采用多变量回归分析评估与术后阿片类药物使用相关的变量。
主要发现
- 接受术前奥昔布宁的患者术后阿片类药物使用率为19%,未接受奥昔布宁的患者为47%。
- 多变量逻辑回归分析显示,术前奥昔布宁与术后接受阿片类药物的风险降低77%相关(比值比0.23,95%CI 0.09-0.56,P<.001)。
- 两组在年龄、手术类型、麻醉阻滞、术后引流管或术中每公斤吗啡毫克当量方面无统计学差异。
关键数值与推荐
- 术前奥昔布宁组术后阿片类药物使用率19%,未使用组47%。
- 多变量逻辑回归:术前奥昔布宁与术后阿片类药物使用风险的比值比0.23(95%CI 0.09-0.56,P<.001)。
临床怎么用
- 原文结论指出,对于泌尿外科术后留置尿道引流管的小儿患者,术前单次奥昔布宁剂量与术后阿片类药物使用率较低显著相关。
- 原文结论指出该风险相对较低的干预措施易于实施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Urologic surgery involving placement of an indwelling ureteral and/or urethral drain can be associated with significant catheter-related bladder discomfort causing increased postoperative morbidity and opioid medication use. We sought to assess if a single dose of oxybutynin given preoperatively reduces immediate postoperative opioid use in common pediatric urology surgeries. MATERIALS AND METHODS: This single-institution retrospective study identified pediatric patients who underwent surgery on the urinary tract with concomitant placement of a urethral and/or ureteral drain. Patients were given a single weight-based dose of oral oxybutynin in the preoperative area prior to surgery. The primary outcome was receipt of postoperative opioid medication. Multivariable regression analyses were used to assess variables associated with postoperative opioid use. RESULTS: A total of 134 patients were included in our final study population with 42 receiving oxybutynin and 92 who did not. There was no statistical difference between the groups in terms of age, procedure type, anesthesia block, postoperative drain, or intraoperative morphine milligram equivalents per kilogram. Patients who received oxybutynin preoperatively had a decrease in postoperative opioid use (19%) compared to those who did not receive oxybutynin (47%). On multivariable logistic regression analysis, preoperative oxybutynin was associated with a 77% reduced risk of receiving postoperative opioid (odds ratio 0.23, [95% CI 0.09-0.56], P < .001). CONCLUSIONS: For pediatric patients with an indwelling urinary drain after urologic surgery, a single preoperative dose of oxybutynin was significantly associated with lower postoperative utilization of opioids. This relatively low-risk intervention can be easily implemented.
引用
- Lin-Brande M, Chakiryan NH, Bayne AP, et al. Preoperative Oxybutynin Reduces Postoperative Opioid Use Following Common Pediatric Urology Surgeries. J Urol. 2024. PMID: 39083537. doi:10.1097/JU.0000000000004162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。